Agency Information Collection Activities: Proposed Collection; Comment Request, 21233-21235 [2017-09090]

Download as PDF Federal Register / Vol. 82, No. 86 / Friday, May 5, 2017 / Notices SRADOVICH on DSK3GMQ082PROD with NOTICES when a PSO chooses to voluntarily relinquish its status as a PSO for any reason, or when a PSO’s listing expires. AHRQ has accepted a notification of voluntary relinquishment from the Empire State Patient Safety Assurance Network PSO of its status as a PSO, and has delisted the PSO accordingly. DATES: The directories for both listed and delisted PSOs are ongoing and reviewed weekly by AHRQ. The delisting was effective at 12:00 Midnight ET (2400) on March 30, 2017. ADDRESSES: Both directories can be accessed electronically at the following HHS Web site: http:// www.pso.ahrq.gov/listed. FOR FURTHER INFORMATION CONTACT: Eileen Hogan, Center for Quality Improvement and Patient Safety, AHRQ, 5600 Fishers Lane, Room 06N94B, Rockville, MD 20857; Telephone (toll free): (866) 403–3697; Telephone (local): (301) 427–1111; TTY (toll free): (866) 438–7231; TTY (local): (301) 427–1130; Email: pso@ahrq.hhs.gov. SUPPLEMENTARY INFORMATION: product (PSWP) in its possession. The PSO will meet the requirements of Section 3.108(c)(2)(i) of the Patient Safety Rule regarding notification to providers that have reported to the PSO. In addition, according to Sections 3.108(c)(2)(ii) and 3.108(b)(3) of the Patient Safety Rule regarding disposition of PSWP, the PSO has 90 days from the effective date of delisting and revocation to complete the disposition of PSWP that is currently in the PSO’s possession. More information on PSOs can be obtained through AHRQ’s PSO Web site at http://www.pso.ahrq.gov. Background The Patient Safety Act authorizes the listing of PSOs, which are entities or component organizations whose mission and primary activity are to conduct activities to improve patient safety and the quality of health care delivery. HHS issued the Patient Safety Rule to implement the Patient Safety Act. AHRQ administers the provisions of the Patient Safety Act and Patient Safety Rule relating to the listing and operation of PSOs. The Patient Safety Rule authorizes AHRQ to list as a PSO an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ‘‘delisted’’ if it is found to no longer meet the requirements of the Patient Safety Act and Patient Safety Rule, when a PSO chooses to voluntarily relinquish its status as a PSO for any reason, or when a PSO’s listing expires. Section 3.108(d) of the Patient Safety Rule requires AHRQ to provide public notice when it removes an organization from the list of federally approved PSOs. AHRQ has accepted a notification from the Empire State Patient Safety Assurance Network, PSO, a component entity of the University of Buffalo, PSO number P0048, to voluntarily relinquish its status as a PSO. Accordingly, the Empire State Patient Safety Assurance Network, PSO was delisted effective at 12:00 Midnight ET (2400) on March 30, 2017. Empire State Patient Safety Assurance Network, PSO has patient safety work Agency Information Collection Activities: Proposed Collection; Comment Request VerDate Sep<11>2014 17:43 May 04, 2017 Jkt 241001 Sharon B. Arnold, Acting Director. [FR Doc. 2017–09091 Filed 5–4–17; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Agency for Healthcare Research and Quality, HHS. ACTION: Notice. AGENCY: This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve the proposed information collection project: ‘‘The AHRQ Safety Program for Improving Antibiotic Use.’’ DATES: Comments on this notice must be received by July 5, 2017. ADDRESSES: Written comments should be submitted to: Doris Lefkowitz, Reports Clearance Officer, AHRQ, by email at doris.lefkowitz@AHRQ.hhs.gov. Copies of the proposed collection plans, data collection instruments, and specific details on the estimated burden can be obtained from the AHRQ Reports Clearance Officer. FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports Clearance Officer, (301) 427–1477, or by email at doris.lefkowitz@AHRQ.hhs.gov. SUPPLEMENTARY INFORMATION: SUMMARY: Proposed Project In accordance with the Paperwork Reduction Act, 44 U.S.C. 3501–3521, AHRQ invites the public to comment on this proposed information collection. Antibiotics can have serious adverse effects including Clostridium difficile PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 21233 infections (CDI), organ dysfunction, allergic reactions, and the development of antibiotic resistance on both a patient level and population level. This project will assist acute care, long-term care and ambulatory care settings across the United States in adopting and implementing antibiotic stewardship programs, which are coordinated efforts to improve the use of antibiotics by promoting the selection of the optimal antibiotic regimen, dose, route of administration, and duration of therapy. More specifically, this project has the following goals: • Identify best practices in the delivery of antibiotic stewardship in the acute care, long-term care and ambulatory care settings • Adapt the Comprehensive Unit-Based Safety Program (CUSP) model to enhance antibiotic stewardship efforts in the health care settings • Assess the adoption of CUSP for antibiotic stewardship and evaluate the effectiveness of the intervention in the participating health care systems • Develop a bundle of technical and adaptive interventions and associated tools and educational materials designed to support enhanced antibiotic stewardship efforts • Provide technical assistance and training to health care organizations nationwide, using a phased approach, to implement effective antibiotic stewardship programs and interventions • Improve communication and teamwork between health care workers surrounding antibiotic decision-making • Improve communication between health care workers and patients/ families surrounding antibiotic decision-making This study is being conducted by AHRQ through its contractor Johns Hopkins University, with subcontracted partner NORC. The AHRQ Safety Program for Improving Antibiotic Use is being undertaken pursuant to AHRQ’s mission to enhance the quality, appropriateness, and effectiveness of health services, and access to such services, through the establishment of a broad base of scientific research and through the promotion of improvements in clinical and health systems practices, including the prevention of diseases and other health conditions. 42 U.S.C. 299. Method of Collection To achieve the goals of this project the following data collections will be implemented: (1) Structural Assessments: A brief (five to seven questions), online E:\FR\FM\05MYN1.SGM 05MYN1 21234 Federal Register / Vol. 82, No. 86 / Friday, May 5, 2017 / Notices Structural Assessment Tool will be administered in all settings at baseline (pre-intervention) and at the end of the intervention period to obtain general information about facilities and existing stewardship infrastructure and changes in stewardship infrastructure and interventions as a result of the AHRQ Safety Program. (2) Team Antibiotic Review Form: The Stewardship Team will conduct monthly reviews of at least 10 patients who received antibiotics and fill out an assessment tool in conjunction with frontline staff to determine if the ‘‘four moments of antibiotic decision-making’’ are being considered by providers. The four moments can be summarized as: (1.) Is an infection present requiring antibiotics? (2.) Were appropriate cultures ordered and best initial choice of antibiotics made? (3.) (after at least 24 hours) Are changes in antibiotic orders appropriate? (4.) What duration of therapy is appropriate? (3) The AHRQ Surveys on Patient Safety Culture will be administered to all participating staff at the beginning and end of the intervention. Each survey asks questions about patient safety issues, medical errors, and event reporting in the respective settings. a. The Hospital Survey on Patient Safety Culture (HSOPS) will be utilized to evaluate safety culture for acute care hospitals. b. The Nursing Home Survey on Patient Safety Culture (NHSOPS) will be administered in long term care. c. The Medical Office Survey on Patient Safety Culture (MOSOPS) will be administered in ambulatory care centers. (4) Semi-structured qualitative interviews: In-person and/or telephone discussions will be held before and after implementation with stewardship champions/organizational leaders, physicians, pharmacists, nurse practitioners, physician assistants, nurses, certified nursing assistants and others deemed relevant, to learn about the facilitators and barriers to a successful antibiotic stewardship program. Specific areas of interest include stakeholder perceptions of implementation process and outcomes, including successes and challenges with carrying out project tasks and perceived utility of the project; staff roles, engagement and support; and antibiotic prescribing etiquette & culture (i.e., social norms and local cultural factors that contribute to prescribing behavior at the facility/unit-level). (5) Electronic Health Record (EHR) data: Unit-level antibiotic usage and clinical outcomes will be extracted from the EHRs of participating health care facilities and used to assess the impact of the AHRQ Safety Program for Improving Antibiotic Use. Estimated Annual Respondent Burden EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Form name Number of responses per respondent Hours per response Total burden hours 1. Structural Assessment ................................................................................. 2. Team Antibiotic Review Form ..................................................................... 3. Surveys on Patient Safety Culture (SOPS): a. HSOPS ................................................................................................. b. NHSOPS .............................................................................................. c. MOSOPS .............................................................................................. 4. Semi-structured qualitative interviews ......................................................... (Physicians—line 1; Other Health Practitioners—line 2) .......................... 5. EHR data ..................................................................................................... 500 333 2 90 0.2 0.2 200 5,994 4,167 4,167 4,167 30 60 500 2 2 2 2 2 12 .5 .5 .5 1 1 .5 4,167 4,167 4,167 60 120 3,000 Total .......................................................................................................... 13,924 N/A N/A 21,875 EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN Number of respondents Form name Total burden hours Average hourly wage rate * Total cost burden 500 333 200 5,994 a $98.83 4,167 4,167 4,167 30 60 500 4,167 4,167 4,167 60 120 3,000 b 27.87 b 27.87 116,134 116,134 116,134 5,930 3,344 83,610 Total .......................................................................................................... SRADOVICH on DSK3GMQ082PROD with NOTICES 1. Structural Assessment ................................................................................. 2. Team Antibiotic Review Form ..................................................................... 3. SOPS: a. HSOPS ................................................................................................. b. NHSOPS .............................................................................................. c. MOSOPS .............................................................................................. 4. Semi-structured qualitative interviews ......................................................... (Physicians—line 1; Other Health Practitioners—line 2) .......................... 5. EHR data ..................................................................................................... 13,924 21,875 N/A 1,053,439 a 98.83 b 27.87 b 27.87 a 98.83 b 27.87 $19,766 592,387 * National Compensation Survey: Occupational wages in the United States May 2016 ‘‘U.S. Department of Labor, Bureau of Labor Statistics:’’ http://www.bls.gov/oes/current/oes_stru.htm. a Based on the mean wages for 29–1069 Physicians and Surgeons, All Other. b Based on the mean wages for 29–9099 Miscellaneous Health Practitioners and Technical Workers: Healthcare Practitioners and Technical Workers, All Other. Request for Comments In accordance with the Paperwork Reduction Act, comments on AHRQ’s information collection are requested VerDate Sep<11>2014 17:43 May 04, 2017 Jkt 241001 with regard to any of the following: (a) Whether the proposed collection of information is necessary for the proper performance of AHRQ health care PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 research and health care information dissemination functions, including whether the information will have practical utility; (b) the accuracy of E:\FR\FM\05MYN1.SGM 05MYN1 Federal Register / Vol. 82, No. 86 / Friday, May 5, 2017 / Notices AHRQ’s estimate of burden (including hours and costs) of the proposed collection(s) of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information upon the respondents, including the use of automated collection techniques or other forms of information technology. Comments submitted in response to this notice will be summarized and included in the Agency’s subsequent request for OMB approval of the proposed information collection. All comments will become a matter of public record. Sharon B. Arnold, Acting Director. [FR Doc. 2017–09090 Filed 5–4–17; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality; Notice of Meetings Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of five AHRQ subcommittee meetings. AGENCY: The subcommittees listed below are part of AHRQ’s Health Services Research Initial Review Group Committee. Grant applications are to be reviewed and discussed at these meetings. Each subcommittee meeting will commence in open session before closing to the public for the duration of the meeting. These meetings will be closed to the public in accordance with 5 U.S.C. App. 2 section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). DATES: See below for dates of meetings: 1. Health Care Research and Training (HCRT) Date: May 25–26, 2017 (Open from 8:00 a.m. to 8:30 a.m. on May 25 and closed for remainder of the meeting) 2. Healthcare Information Technology Research (HITR) Date: June 7–9, 2017 (Open from 6:00 p.m. to 6:30 p.m. on June 7 and closed for remainder of the meeting) 3. Health System and Value Research (HSVR) Date: June 14–15, 2017 (Open from 8:30 a.m. to 9:00 a.m. on June 14 and closed for remainder of the meeting) 4. Healthcare Effectiveness and Outcomes Research (HEOR) Date: June 14–15, 2017 (Open from 8:30 a.m. to 9:00 a.m. on June 14 SRADOVICH on DSK3GMQ082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:43 May 04, 2017 Jkt 241001 and closed for remainder of the meeting) 5. Healthcare Safety and Quality Improvement Research (HSQR) Date: June 22–23, 2017 (Open from 8:00 a.m. to 8:30 a.m. on June 22 and closed for remainder of the meeting) DEPARTMENT OF HEALTH AND HUMAN SERVICES ADDRESSES: (Below specifics where each hotel will be held) AGENCY: Gaithersburg Marriott, 9751 Washingtonian Blvd., Gaithersburg, Maryland 20878. SUMMARY: (To obtain a roster of members, agenda or minutes of the non-confidential portions of the meetings.) FOR FURTHER INFORMATION CONTACT: Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research Education and Priority Populations, Agency for Healthcare Research and Quality (AHRQ), 5600 Fishers Lane, Rockville, Maryland 20857, Telephone (301) 427–1554. BILLING CODE 4160–90–P 21235 SUPPLEMENTARY INFORMATION: In accordance with section 10 (a)(2) of the Federal Advisory Committee Act (5 U.S.C. App. 2), AHRQ announces meetings of the above-listed scientific peer review groups, which are subcommittees of AHRQ’s Health Services Research Initial Review Group Committees. Each subcommittee meeting will commence in open session before closing to the public for the duration of the meeting. The subcommittee meetings will be closed to the public in accordance with the provisions set forth in 5 U.S.C. App. 2 section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6) The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Agenda items for these meetings are subject to change as priorities dictate. Sharon B. Arnold, Acting Director. [FR Doc. 2017–09130 Filed 5–4–17; 8:45 am] BILLING CODE 4160–90–P PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 Agency for Healthcare Research and Quality Agency Information Collection Activities: Proposed Collection; Comment Request Agency for Healthcare Research and Quality, HHS. ACTION: Notice. This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve the proposed information collection project ‘‘The Reengineered Visit for Primary Care.’’ This proposed information collection was previously published in the Federal Register on February 13, 2017 and allowed 60 days for public comment. AHRQ received one comment from the public. The purpose of this notice is to allow an additional 30 days for public comment. DATES: Comments on this notice must be received by June 5, 2017. ADDRESSES: Written comments should be submitted to: AHRQ’s OMB Desk Officer by fax at (202) 395–6974 (attention: AHRQ’s desk officer) or by email at OIRA_submission@ omb.eop.gov (attention: AHRQ’s desk officer). FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports Clearance Officer, (301) 427–1477, or by email at doris.lefkowitz@AHRQ.hhs.gov. SUPPLEMENTARY INFORMATION: Proposed Project The Re-Engineered Visit for Primary Care In accordance with the Paperwork Reduction Act, 44 U.S.C. 3501–3521, AHRQ invites the public to comment on this proposed information collection. This project, The Re-engineered Visit for Primary Care, directly addresses the agency’s goal to conduct research to enhance the quality of health care and reduce avoidable readmissions, which are a major indicator of poor quality and patient safety. Research from AHRQ’s Healthcare Cost and Utilization Project (HCUP) indicates that in 2011 there were approximately 3.3 million adult hospital readmissions in the United States. Adults covered by Medicare have the highest readmission rate (17.2 per 100 admissions), followed by adults covered by Medicaid (14.6 per 100 admissions) and privately insured adults (8.7 per E:\FR\FM\05MYN1.SGM 05MYN1

Agencies

[Federal Register Volume 82, Number 86 (Friday, May 5, 2017)]
[Notices]
[Pages 21233-21235]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-09090]


-----------------------------------------------------------------------

 DEPARTMENT OF HEALTH AND HUMAN SERVICES

 Agency for Healthcare Research and Quality


Agency Information Collection Activities: Proposed Collection; 
Comment Request

AGENCY: Agency for Healthcare Research and Quality, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces the intention of the Agency for 
Healthcare Research and Quality (AHRQ) to request that the Office of 
Management and Budget (OMB) approve the proposed information collection 
project: ``The AHRQ Safety Program for Improving Antibiotic Use.''

DATES: Comments on this notice must be received by July 5, 2017.

ADDRESSES: Written comments should be submitted to: Doris Lefkowitz, 
Reports Clearance Officer, AHRQ, by email at 
doris.lefkowitz@AHRQ.hhs.gov.
    Copies of the proposed collection plans, data collection 
instruments, and specific details on the estimated burden can be 
obtained from the AHRQ Reports Clearance Officer.

FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports 
Clearance Officer, (301) 427-1477, or by email at 
doris.lefkowitz@AHRQ.hhs.gov.

SUPPLEMENTARY INFORMATION:

Proposed Project

    In accordance with the Paperwork Reduction Act, 44 U.S.C. 3501-
3521, AHRQ invites the public to comment on this proposed information 
collection. Antibiotics can have serious adverse effects including 
Clostridium difficile infections (CDI), organ dysfunction, allergic 
reactions, and the development of antibiotic resistance on both a 
patient level and population level. This project will assist acute 
care, long-term care and ambulatory care settings across the United 
States in adopting and implementing antibiotic stewardship programs, 
which are coordinated efforts to improve the use of antibiotics by 
promoting the selection of the optimal antibiotic regimen, dose, route 
of administration, and duration of therapy.
    More specifically, this project has the following goals:

 Identify best practices in the delivery of antibiotic 
stewardship in the acute care, long-term care and ambulatory care 
settings
 Adapt the Comprehensive Unit-Based Safety Program (CUSP) model 
to enhance antibiotic stewardship efforts in the health care settings
 Assess the adoption of CUSP for antibiotic stewardship and 
evaluate the effectiveness of the intervention in the participating 
health care systems
 Develop a bundle of technical and adaptive interventions and 
associated tools and educational materials designed to support enhanced 
antibiotic stewardship efforts
 Provide technical assistance and training to health care 
organizations nationwide, using a phased approach, to implement 
effective antibiotic stewardship programs and interventions
 Improve communication and teamwork between health care workers 
surrounding antibiotic decision-making
 Improve communication between health care workers and 
patients/families surrounding antibiotic decision-making

    This study is being conducted by AHRQ through its contractor Johns 
Hopkins University, with subcontracted partner NORC. The AHRQ Safety 
Program for Improving Antibiotic Use is being undertaken pursuant to 
AHRQ's mission to enhance the quality, appropriateness, and 
effectiveness of health services, and access to such services, through 
the establishment of a broad base of scientific research and through 
the promotion of improvements in clinical and health systems practices, 
including the prevention of diseases and other health conditions. 42 
U.S.C. 299.

Method of Collection

    To achieve the goals of this project the following data collections 
will be implemented:
    (1) Structural Assessments: A brief (five to seven questions), 
online

[[Page 21234]]

Structural Assessment Tool will be administered in all settings at 
baseline (pre-intervention) and at the end of the intervention period 
to obtain general information about facilities and existing stewardship 
infrastructure and changes in stewardship infrastructure and 
interventions as a result of the AHRQ Safety Program.
    (2) Team Antibiotic Review Form: The Stewardship Team will conduct 
monthly reviews of at least 10 patients who received antibiotics and 
fill out an assessment tool in conjunction with frontline staff to 
determine if the ``four moments of antibiotic decision-making'' are 
being considered by providers. The four moments can be summarized as: 
(1.) Is an infection present requiring antibiotics? (2.) Were 
appropriate cultures ordered and best initial choice of antibiotics 
made? (3.) (after at least 24 hours) Are changes in antibiotic orders 
appropriate? (4.) What duration of therapy is appropriate?
    (3) The AHRQ Surveys on Patient Safety Culture will be administered 
to all participating staff at the beginning and end of the 
intervention. Each survey asks questions about patient safety issues, 
medical errors, and event reporting in the respective settings.
    a. The Hospital Survey on Patient Safety Culture (HSOPS) will be 
utilized to evaluate safety culture for acute care hospitals.
    b. The Nursing Home Survey on Patient Safety Culture (NHSOPS) will 
be administered in long term care.
    c. The Medical Office Survey on Patient Safety Culture (MOSOPS) 
will be administered in ambulatory care centers.
    (4) Semi-structured qualitative interviews: In-person and/or 
telephone discussions will be held before and after implementation with 
stewardship champions/organizational leaders, physicians, pharmacists, 
nurse practitioners, physician assistants, nurses, certified nursing 
assistants and others deemed relevant, to learn about the facilitators 
and barriers to a successful antibiotic stewardship program. Specific 
areas of interest include stakeholder perceptions of implementation 
process and outcomes, including successes and challenges with carrying 
out project tasks and perceived utility of the project; staff roles, 
engagement and support; and antibiotic prescribing etiquette & culture 
(i.e., social norms and local cultural factors that contribute to 
prescribing behavior at the facility/unit-level).
    (5) Electronic Health Record (EHR) data: Unit-level antibiotic 
usage and clinical outcomes will be extracted from the EHRs of 
participating health care facilities and used to assess the impact of 
the AHRQ Safety Program for Improving Antibiotic Use.

Estimated Annual Respondent Burden

                                  Exhibit 1--Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of
                    Form name                        Number of     responses per     Hours per     Total burden
                                                    respondents     respondent       response          hours
----------------------------------------------------------------------------------------------------------------
1. Structural Assessment........................             500               2             0.2             200
2. Team Antibiotic Review Form..................             333              90             0.2           5,994
3. Surveys on Patient Safety Culture (SOPS):
    a. HSOPS....................................           4,167               2              .5           4,167
    b. NHSOPS...................................           4,167               2              .5           4,167
    c. MOSOPS...................................           4,167               2              .5           4,167
4. Semi-structured qualitative interviews.......              30               2               1              60
    (Physicians--line 1; Other Health                         60               2               1             120
     Practitioners--line 2).....................
5. EHR data.....................................             500              12              .5           3,000
                                                 ---------------------------------------------------------------
    Total.......................................          13,924             N/A             N/A          21,875
----------------------------------------------------------------------------------------------------------------


                                   Exhibit 2--Estimated Annualized Cost Burden
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                    Form name                        Number of     Total burden     hourly wage     Total cost
                                                    respondents        hours          rate *          burden
----------------------------------------------------------------------------------------------------------------
1. Structural Assessment........................             500             200      \a\ $98.83         $19,766
2. Team Antibiotic Review Form..................             333           5,994       \a\ 98.83         592,387
3. SOPS:
    a. HSOPS....................................           4,167           4,167       \b\ 27.87         116,134
    b. NHSOPS...................................           4,167           4,167       \b\ 27.87         116,134
    c. MOSOPS...................................           4,167           4,167       \b\ 27.87         116,134
4. Semi-structured qualitative interviews.......              30              60       \a\ 98.83           5,930
    (Physicians--line 1; Other Health                         60             120       \b\ 27.87           3,344
     Practitioners--line 2).....................
5. EHR data.....................................             500           3,000       \b\ 27.87          83,610
                                                 ---------------------------------------------------------------
    Total.......................................          13,924          21,875             N/A       1,053,439
----------------------------------------------------------------------------------------------------------------
* National Compensation Survey: Occupational wages in the United States May 2016 ``U.S. Department of Labor,
  Bureau of Labor Statistics:'' http://www.bls.gov/oes/current/oes_stru.htm.
\a\ Based on the mean wages for 29-1069 Physicians and Surgeons, All Other.
\b\ Based on the mean wages for 29-9099 Miscellaneous Health Practitioners and Technical Workers: Healthcare
  Practitioners and Technical Workers, All Other.

Request for Comments

    In accordance with the Paperwork Reduction Act, comments on AHRQ's 
information collection are requested with regard to any of the 
following: (a) Whether the proposed collection of information is 
necessary for the proper performance of AHRQ health care research and 
health care information dissemination functions, including whether the 
information will have practical utility; (b) the accuracy of

[[Page 21235]]

AHRQ's estimate of burden (including hours and costs) of the proposed 
collection(s) of information; (c) ways to enhance the quality, utility, 
and clarity of the information to be collected; and (d) ways to 
minimize the burden of the collection of information upon the 
respondents, including the use of automated collection techniques or 
other forms of information technology.
    Comments submitted in response to this notice will be summarized 
and included in the Agency's subsequent request for OMB approval of the 
proposed information collection. All comments will become a matter of 
public record.

Sharon B. Arnold,
Acting Director.
[FR Doc. 2017-09090 Filed 5-4-17; 8:45 am]
BILLING CODE 4160-90-P